Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001291573 | SCV001480108 | pathogenic | not provided | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000001462 | SCV001585102 | pathogenic | Leber congenital amaurosis 3 | 2023-03-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the SPATA7 protein in which other variant(s) (p.Asn454Lysfs*2) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1397). This premature translational stop signal has been observed in individuals with juvenile-onset retinitis pigmentosa (PMID: 19268277, 21602930). This variant is present in population databases (rs75895925, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Arg395*) in the SPATA7 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 205 amino acid(s) of the SPATA7 protein. |
Gene |
RCV001291573 | SCV002820712 | pathogenic | not provided | 2023-01-06 | criteria provided, single submitter | clinical testing | Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 205 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD; ); This variant is associated with the following publications: (PMID: 20301475, 32799588, 27422788, 25525159, 19268277, 31908400, 32141364, 27375279, 25814828, 21310915, 21602930, 20104588, 31589614) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003485517 | SCV004242053 | pathogenic | Leber congenital amaurosis | 2023-12-08 | criteria provided, single submitter | clinical testing | Variant summary: SPATA7 c.1183C>T (p.Arg395X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 4.8e-05 in 250134 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SPATA7 causing Leber Congenital Amaurosis (4.8e-05 vs 0.00087), allowing no conclusion about variant significance. c.1183C>T has been reported either at a homozygous state or in trans along with a second pathogenic variant in at-least three individuals affected with early-onset ocular diseases including poor vision, ocular digital sign, fundus changes of attenuated vessels, tapetoretinal degeneration, retina degeneration, and/or extinguished ERG recording of rods and cones (example, Xiao_2019). These data indicate that the variant is likely to be associated with Leber Congenital Amaurosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 31908400). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Dept Of Ophthalmology, |
RCV003887848 | SCV004707785 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
OMIM | RCV002260581 | SCV000021617 | pathogenic | Retinitis pigmentosa 94, variable age at onset | 2009-03-01 | no assertion criteria provided | literature only | |
Gene |
RCV000001462 | SCV000086977 | not provided | Leber congenital amaurosis 3 | no assertion provided | literature only | ||
Laboratory of Genetics in Ophthalmology, |
RCV000001462 | SCV001432525 | pathogenic | Leber congenital amaurosis 3 | no assertion criteria provided | research |